1 IVUS) or conventional angiography at a large
single center.
2 extend the results previously obtained in a
single center.
3 ctivity influenced waitlisted outcomes for a
single center.
4 7 actively managed MS patients enrolled at a
single center.
5 ndrome) who were followed up for 1 year at a
single center.
6 e care intervention (UC + PAL) (n = 75) at a
single center.
7 /TEN from a registry of DILI patients from a
single center.
8 scribe the outcome over a 14-y period from a
single center.
9 258 smokers) studied from 2001 to 2005 in a
single center.
10 1 patients were consecutively performed in a
single center.
11 rolimus/mycophenolate immunosuppression at a
single center.
12 t Database and a nested cohort analysis of a
single center.
13 transplants performed in 95 recipients at a
single center.
14 The images were graded at a
single center.
15 Among the 201 patients treated at the
single center (
108 men [53.7%] and 93 women [46.3%]; med
16 In a
single center,
a cluster of M. hominis infections were i
17 This was a
single-center analysis of 78 eyes of 58 patients that un
18 In a retrospective,
single-center analysis, 523 patients undergoing heart tr
19 ter standard chemotherapy were enrolled at a
single center and randomized to watch and wait (n = 9),
20 h acute kidney injury have been described in
single-center and retrospective studies.
21 ble Vascular Scaffold Stents II) trial was a
single-center,
assessor-blinded study of 240 patients ra
22 Prospective
single-center before and after study.
23 ian age, 49 years) who had BL diagnosed at a
single center between 1986 and 2014 and were followed up
24 ergoing diagnostic lumbar puncture (LP) at a
single center between 2011 and 2015 were included in the
25 essive benign or low-grade brain tumors at a
single center between April 2001 to March 2012.
26 Ms) occurring in rotary LVADs implanted at a
single center between April 2004 and May 2016.
27 with 124 primary HCCs who were treated at a
single center between January 2011 and March 2014.
28 , 58 years; male patients, 434 [62.8%]) in a
single center between June 2013 and August 2014 were ret
29 ult kidney transplantation transplanted at a
single-center between 2005 and 2012.
30 Investigator-initiated,
single center,
blinded, randomized clinical trial in hig
31 In this
single-center Brazilian cohort, ZIKV infection was assoc
32 state MR imaging examinations performed at a
single center by using the PI-RADS lexicon.
33 1, 2016, were included in this retrospective
single-center case series at a private vitreoretinal pra
34 osthesis type II implantation in the largest
single-center case series with the longest average follo
35 A prospective,
single-center,
case-control study was conducted from Aug
36 Setting:
Single-center children's hospital.
37 In a
single-center clinical feasibility study, 35 patients un
38 2014 at Boston Foundation for Sight (BFS), a
single-center clinical practice, was reviewed to identif
39 wed for at least 6 months in a retrospective
single-center cohort (mean time of follow-up, 5.2 years;
40 We investigated a
single-center cohort of 340 lung transplant recipients u
41 A
single-center cohort of 3646 patients underwent inpatien
42 In a
single-center cohort of 51,457 adult surgical patients u
43 This hypothesis was tested in a
single-center cohort of 577 kidney transplant patients.
44 A
single-center cohort of patients undergoing coronary or
45 to compare the overall survival of a large,
single-center cohort of patients who had differentiated
46 A
single-center cohort representing 664 admissions for ind
47 In a prospective,
single-center cohort study (N=487), we assessed frailty
48 Materials and Methods This prospective
single-center cohort study was approved by the instituti
49 A
single-center cohort study was conducted among patients
50 A
single-center cohort study was conducted between Septemb
51 A prospective,
single-center cohort study was conducted.
52 We conducted a prospective,
single-center cohort study, including 907 patients with
53 In a
single-center cohort study, we evaluated 18 patients wit
54 rtile range, 3.8-9.6) years in a prospective
single-center cohort study.
55 sma-derived proteins, previously assessed in
single-center cohorts, with clinical outcomes after allo
56 METHODS AND In this
single-center,
community-based, retrospective study of a
57 We conducted a retrospective
single-center comparative cohort study from January 1, 2
58 METHODS AND A
single-center continuous flow-LVAD database (n=354) was
59 This
single-center,
cross-sectional comparative study was con
60 A prospective,
single-center,
cross-sectional controlled study was cond
61 Design, Setting, and Participants: Three
single-center,
cross-sectional studies were performed in
62 and Participants: A prospectively collected
single-center database containing all laparoscopic liver
63 With the exception of a few
single-center descriptive reports, data on critical care
64 ncy department sedation are limited by their
single-center design and are underpowered to identify ri
65 In a
single-center,
double-blind, noninferiority trial involv
66 Single-center,
double-blind, parallel-group, randomized
67 We performed a
single-center,
double-blind, placebo-controlled trial of
68 Prospective, randomized,
single-center equivalence trial.
69 A
single-center,
evaluator-blinded, randomized clinical st
70 This multicenter study validated
single-center evidence that patients who received kidney
71 anges, and Methodist San Antonio, which runs
single-center exchanges-to study how the frequency of ma
72 We report a 50-year
single-center experience of 1007 patients, which raised
73 We report our
single-center experience with a specially developed prot
74 Purpose To review a
single-center experience with the cortical tangential ap
75 membrane oxygenation are mainly confined to
single-center experiences or specific pathogens.
76 Prospective
single center exploratory case series.
77 In this prospective,
single-center feasibility study, 13 patients with cardio
78 rol nonobstetric population was drawn from a
single-center general critical care population (n = 2,46
79 Patients with a VH from a
single-center hernia clinic were prospectively enrolled
80 Materials and Methods This prospective,
single-center,
HIPAA-compliant study was approved by the
81 Methods In this retrospective, longitudinal,
single-center,
HIPAA-compliant, institutional review boa
82 er RETRACE study (n = 542), (2) a U.S.-based
single-center ICH study (n = 261), and (3) the Ethnic/Ra
83 ed from March 1, 2016, to May 25, 2017, at a
single center in Italy.
84 The study was performed at a
single center in South Africa.
85 tudy sought to evaluate LQTS outcomes from a
single center in the contemporary era.
86 molecule that combines both challenges in a
single center in the form of exochomine.
87 ized double-blinded trial was conducted in a
single center in the United Kingdom.
88 his phase 2, open-label study conducted at a
single center in the United States, patients with HCV ge
89 A report from a high-volume
single center indicated a survival benefit of receiving
90 In this phase IIA open-label,
single-center,
intra-patient, dose-escalating study, adu
91 The study was a
single-center,
investigator-driven, double-masked, block
92 A
single center IRB approved study included 874 patients.
93 with gene therapy over the same period at a
single center level: the Necker Children's Hospital (Par
94 higher after implementation of Share 35 in a
single center located in region 5.
95 This prospective,
single-center,
longitudinal cohort study of adult patien
96 Ten year,
single-center,
longitudinal cohort study of kidney recip
97 This
single-center,
masked, sham-controlled randomized clinic
98 Reviewing
single-center medical records, we identified all patient
99 A retrospective
single-center multivariate regression analysis was perfo
100 rospective, cross-sectional study examined a
single-center neuropathologic CAA cohort of eligible pat
101 The results of this
single-center,
nonblinded study among selected pregnant
102 In this randomized,
single-center,
nonblinded trial, we included patients wi
103 Prospective,
single-center,
nonblinded, randomized controlled trial.
104 In a phase II open label
single center noncomparative clinical trial under GCP st
105 MIPD seem promising, but most data come from
single-center,
noncomparative series.
106 We present a preliminary
single-center North American experience using identical
107 plantation (LT) with donors >/=70 years in a
single center not applying specific donor/recipient matc
108 Prospective
single-center observational cohort study.
109 Limitation: Data are from a
single-center observational study (albeit conducted in a
110 A
single-center observational study was performed on 94 pa
111 This was a
single-center,
observational cohort study of patients wi
112 In a
single-center,
observational study involving 319 decease
113 A prospective,
single-center,
observational study with systematic docum
114 Cross-sectional,
single-center,
observational study.
115 In this
single-center,
observational, prospective cohort study,
116 This was a prospective, randomized,
single-center,
open, 2-period crossover platelet functio
117 In a phase 2/3,
single-center,
open-label trial, participants from Ontar
118 In this
single-center,
open-label, phase 2a trial, 34 participan
119 ign, Setting, and Patients: Oxygen-ICU was a
single-center,
open-label, randomized clinical trial con
120 tory bowel disease (IBD) have used data from
single centers or CDI administrative data codes of limit
121 Previous studies have been limited to
single centers or lacked detailed clinical data.
122 re carried out using a uniform protocol at a
single-center organ procurement organization.
123 This univariate retrospective analysis of a
single center/
organ procurement organization use of HbA1
124 We report
single center outcomes for kidneys transplanted from DCD
125 mized, evaluator-blinded clinical trial in a
single-center outpatient academic dermatology center.
126 oietic cell transplant (HCT) recipients at a
single center over a 10-year period were reviewed retros
127 cblC deficiency systematically examined at a
single center over an extended period.
128 In this academic,
single-center,
parallel-group, prospective, randomized,
129 Design, Setting, and Participants:
Single-center phase 1 clinical trial conducted in the Un
130 Patients and Methods In this
single-center phase II trial, treatment-naive patients r
131 In this
single-center phase-2 study, newly diagnosed PCNSL patie
132 rolled in a physician-initiated, open-label,
single-center,
phase 2 clinical trial of brentuximab ved
133 In this
single-center,
phase 2 study, 48 patients with relapsed/
134 Open-label,
single-center,
phase 2b pilot study of previously untrea
135 We conducted a
single-center,
placebo-controlled, randomized study inve
136 This was a
single-center,
pragmatic, randomized trial.
137 This
single-center,
pre-post, quasiexperimental study evaluat
138 Single center prospective double blind randomized contro
139 Single center prospective double blinded randomized stud
140 This was a
single-center prospective clinical study including healt
141 This is a
single-center prospective cohort study of 83 nondiabetic
142 This was a
single-center prospective cohort study using the TAYBRID
143 Single-center prospective cohort study.
144 S was conducted among children enrolled in a
single-center prospective consecutive cohort at The Chil
145 This was a
single-center prospective interventional cases series.
146 This was a predefined subanalysis of a
single-center prospective randomized study in which 288
147 We performed a
single-center prospective randomized study in which duod
148 We conducted a
single-center prospective study of children receiving me
149 This
single-center prospective study was compliant with HIPAA
150 ith Acute Decompensated Heart Failure) was a
single-center prospective study, which enrolled patients
151 Design, Setting, and Participants: This
single-center prospective, controlled, observer-blinded
152 In this observational,
single-center,
prospective cohort study, we studied 72 p
153 This is a
single-center,
prospective cohort study.
154 Single-center,
prospective cohort, as well as secondary
155 Single-center,
prospective noninferiority study.
156 This
single-center,
prospective study performed in a private
157 In this
single-center,
prospective, cross-sectional case series,
158 ember 2011 and December 2016, we conducted a
single-center,
prospective, double-blind trial of 39 pat
159 In a
single-center,
prospective, nonrandomized comparison stu
160 A 2-year,
single-center,
prospective, participant- and surgeon-mas
161 This
single-center,
prospective, randomized, controlled, open
162 We performed an open-label,
single-center,
prospective, randomized, cross-over study
163 This
single-center,
prospective, randomized, crossover, open-
164 was an institutional review board-approved,
single-center,
prospective, randomized, parallel-group,
165 Single-center,
prospective, randomized, pilot study.
166 M between 1992 and 2012 were included from a
single-center prospectively maintained database.
167 Retrospective,
single-center quasi-experimental study of hospitalized p
168 hat usually assumes ordinary open shells for
single-centered radicals needs modification to take into
169 Single-center randomized clinical trial of 231 criticall
170 Single-center randomized clinical trial of 83 patients w
171 A
single-center randomized clinical trial was conducted us
172 We did a parallel, open-label
single-center randomized controlled trial at three inten
173 RATIONALE:
Single-center randomized controlled trials of the Zephyr
174 We conducted a
single-center randomized trial to compare the efficacy o
175 Single center,
randomized, double-blind controlled trial
176 Single-center,
randomized clinical trial at Wake Forest
177 A double-blind,
single-center,
randomized clinical trial conducted withi
178 In this
single-center,
randomized clinical trial, patients under
179 We conducted a
single-center,
randomized controlled trial.
180 This
single-center,
randomized double-blind, placebo-controll
181 This is a
single-center,
randomized placebo-controlled crossover c
182 In this
single-center,
randomized, controlled trial, we evaluate
183 bation for Endovascular Stroke Treatment), a
single-center,
randomized, parallel-group, open-label tr
184 Single-center,
randomized, placebo-controlled, observer-
185 : 100 aortic valvuloplasties from a previous
single-center report (excluded from additional reporting
186 In the largest
single-center report of recurrent HCC following LT, surg
187 Single-center reports demonstrate large variation in out
188 The method used in this study was
single-center retrospective analysis of 207 liver transp
189 Single-center retrospective analysis of prospectively co
190 Design, Setting, and Participants:
Single-center retrospective case series of 38 consecutiv
191 Single-center retrospective case series.
192 In this
single-center retrospective cohort study of 2749 adult N
193 Single-center retrospective cohort study.
194 Materials and Methods This was a
single-center retrospective institutional review board-a
195 A
single-center retrospective review of all patients suppo
196 This is a
single-center retrospective review of prospectively enro
197 Materials and Methods This
single-center retrospective study and meta-analysis was
198 This was a
single-center retrospective study of all deceased donor
199 Materials and Methods This HIPAA-compliant,
single-center retrospective study was approved by the in
200 This
single-center retrospective study was approved by the in
201 The aim of this
single-center retrospective study was to correlate speci
202 review board approval was obtained for this
single-center retrospective study, with waiver of inform
203 This was a
single-center retrospective U.K. cohort study.
204 In a
single center,
retrospective, Cross-sectional, observati
205 This was a
single-center,
retrospective analysis of electronic heal
206 In this
single-center,
retrospective analysis, an MPD diameter o
207 Single-center,
retrospective case series.
208 We present a
single-center,
retrospective cohort of patients with ant
209 We performed a
single-center,
retrospective cohort study between 2011 a
210 This was a
single-center,
retrospective cohort study of adult, nonn
211 This
single-center,
retrospective cohort study was conducted
212 This
single-center,
retrospective cohort study was conducted
213 Single-center,
retrospective cohort study.
214 This was a
single-center,
retrospective review of children with DCM
215 This was a
single-center,
retrospective review of imaging and inter
216 This is a
single-center,
retrospective study of 594 adults with PC
217 Materials and Methods This
single-center,
retrospective study was approved by the i
218 In this
single-center,
retrospective, longitudinal study, diseas
219 A
single-center,
retrospective, observational cohort study
220 A
single-center,
retrospective, observational, comparative
221 METHODS AND A
single-center review of all patients implanted with a He
222 A retrospective
single-center review of Employee Health and Wellness Ser
223 We undertook a
single-center review of spinal injured adults hospitaliz
224 examined the outcomes of MLs in the largest
single center series of MLs used to date and compared ou
225 Conclusion This post hoc analysis of the
single-center SIESTA trial revealed that time from groin
226 Single-center,
single-arm, open-label phase 2 trial of C
227 t larger than previously reported in smaller
single-center studies but comparable to that of gastroin
228 Single-center studies have reported an association betwe
229 Single-center studies have shown that 4q25 risk alleles
230 Single-center studies identify frailty as a risk factor
231 Previous smaller,
single-center studies showed that LVSD following brain d
232 Single-center studies suggest that neonatal acute kidney
233 has not been conducted, results from small,
single-center studies support this notion.
234 (OTRs), but evidence from multiple, largely
single-center studies to date has been inconsistent.
235 In smaller
single-center studies, patients with cirrhosis are at a
236 In
single-center studies, technetium 99m pyrophosphate (Tc
237 escriptions of outcomes are limited to small
single-center studies.
238 y have been limited to small, nonrandomized,
single-center studies.
239 n have been described in clinical trials and
single-center studies.
240 pansion was lower than in prior reports from
single-center studies.
241 e respiratory distress syndrome in small and
single-center studies; however, comprehensive studies of
242 onclusions and Relevance: This retrospective
single center study indicates that ICL implantation prov
243 In a
single center study, patients with RCDI (n = 20) receive
244 aneurysms were seen at follow-up DSA in the
single-center study (0.0%).
245 This phase 1b/2, observer-blind,
single-center study (NCT01193920) enrolled infants born
246 The setting was a
single-center study at the National Institutes of Health
247 We report the findings of a prospective,
single-center study conducted in patients with diverse r
248 post hoc analysis of data from a prospective
single-center study for which informed consent was obtai
249 This observational
single-center study included a cohort of consecutive end
250 This
single-center study involving Ugandan infants with posti
251 This large
single-center study is the first donor outcome report fr
252 Observational
single-center study of 509 consecutive patients treated
253 Single-center study of 58 eyes of 56 patients who receiv
254 PROWL-1 was a
single-center study of active-duty US Navy personnel and
255 Retrospective
single-center study of all LT since the start of DCD pro
256 This was a prospective,
single-center study of patients in the ED with moderate
257 Cross-sectional
single-center study that took place at the Department of
258 We conducted a retrospective
single-center study to characterize cases of C4d-negativ
259 A retrospective,
single-center study was conducted of all adults (n = 128
260 The aim of this
single-center study was to investigate whether obtaining
261 In this
single-center study we showed that adding the Early Warn
262 Randomized, assessor-blinded,
single-center study within Region Zealand and the Capita
263 In this prospective
single-center study, 126 intraoperative tissue biopsies
264 In this
single-center study, 310 consecutive DMEK operations for
265 In this
single-center study, among healthy individuals cleared f
266 In a prospective, longitudinal
single-center study, RNA samples from circulating leukoc
267 In this institutional review board-approved
single-center study, signal intensities from T1-weighted
268 METHODS AND In this retrospective,
single-center study, we analyzed data from 230 patients
269 In this prospective
single-center study, we instituted a universal surgical
270 approved this HIPAA-compliant retrospective
single-center study, which included 100 consecutive pati
271 ant prognostic value independent of GEP, our
single-center study, which included a substantial propor
272 ce (MR) elastography of the liver in a large
single-center study.
273 or this prospective, randomized, open-label,
single-center study.
274 placebo-controlled, parallel-group phase II
single-center study.
275 This was a retrospective
single-center study.
276 is prospective, observational, longitudinal,
single-center study.
277 ere enrolled in a prospective, longitudinal,
single-center study.
278 At a
single center,
subjects enrolled into phase 2 and 3 C. d
279 Single center tertiary level ICU.
280 Single-center tertiary care practice.
281 p) or clinical observation (test group) at a
single-center tertiary referral teaching hospital.
282 After a
single-center trial and observational studies suggesting
283 enolate mofetil in an investigator-initiated
single-center trial in Hannover, Germany.
284 C-SWIFT was an open-label,
single-center trial in treatment-naive patients with chr
285 is randomized clinical and partially blinded
single-center trial was conducted in a neonatal tertiary
286 In this
single-center trial, children and adolescents with drug-
287 In a
single-center trial, tDCS for the treatment of depressio
288 In this
single-center trial, we randomly assigned 116 patients w
289 ed to replicate the findings of the original
single-center trial.
290 median, 12.3 [IQR, 5.4-24.1]), and more than
single-center trials (n = 116; median, 6.8 [IQR, 3.5-12.
291 lecular imaging in oncology have been small,
single-center trials.
292 This
single-center,
unblinded, randomized clinical trial comp
293 or End-Stage Liver Disease (MELD) >/=12 at a
single center underwent functional status assessments at
294 d healthy subjects (n = 49) recruited from a
single center underwent QCT and clinical characterizatio
295 ity after HTX over a period of 10 years at a
single-center university hospital.
296 logically confirmed cardiac amyloidosis at a
single center with electrocardiography, echocardiography
297 Data collection was limited to a
single center with generalizability limitations.
298 Retinoblastoma patients treated at a
single center with intravenous chemotherapy and IVM.
299 eral hand allotransplantation performed in a
single center,
with a follow-up ranging from 3 to 13 yea
300 inopelvic surgeries from 2008 to 2014 from a
single center within the Michigan Surgical Quality Colla